All Stories

  1. Virus-like particle-mediated intracellular delivery of mRNA cap analog with in vivo activity against hepatocellular carcinoma
  2. Gold-decorated polymer vessel structures as carriers of mRNA cap analogs
  3. Five eIF4E isoforms from Arabidopsis thaliana are characterized by distinct features of cap analogs binding
  4. Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes
  5. Cap analogs containing 6-thioguanosine – reagents for the synthesis of mRNAs selectively photo-crosslinkable with cap-binding biomolecules
  6. Towards novel efficient and stable nuclear import signals: synthesis and properties of trimethylguanosine cap analogs modified within the 5′,5′-triphosphate bridge
  7. Synthesis and evaluation of stability of m3G-CAP analogues in serum-supplemented medium and cytosolic extract
  8. Analysis of decapping scavenger cap complex using modified cap analogs reveals molecular determinants for efficient cap binding
  9. The synthesis of isopropylidene mRNA cap analogs modified with phosphorothioate moiety and their evaluation as promoters of mRNA translation
  10. Magnetic-Nanoparticle-Decorated Polypyrrole Microvessels: Toward Encapsulation of mRNA Cap Analogues
  11. Potential therapeutic applications of RNA cap analogs
  12. A fast and simple method enabling synthesis of nucleotide sugars.
  13. Synthesis and evaluation of fluorescent cap analogues for mRNA labelling
  14. mRNAs containing the histone 3' stem-loop are degraded primarily by decapping mediated by oligouridylation of the 3' end
  15. Synthetic mRNAs with Superior Translation and Stability Properties
  16. 7-Methylguanosine Diphosphate (m 7 GDP) Is Not Hydrolyzed but Strongly Bound by Decapping Scavenger (DcpS) Enzymes and Potently Inhibits Their Activity
  17. Preparation of Synthetically Challenging Nucleotides Using Cyanoethyl P-Imidazolides and Microwaves
  18. Synthesis of nucleoside phosphosulfates
  19. Affinity resins containing enzymatically resistant mRNA cap analogs--a new tool for the analysis of cap-binding proteins
  20. Synthesis and properties of mRNA cap analogs containing imidodiphosphate moiety—fairly mimicking natural cap structure, yet resistant to enzymatic hydrolysis
  21. Synthesis of biotin labelled cap analogue – incorporable into mRNA transcripts and promoting cap-dependent translation
  22. Structural analysis of 5′-mRNA–cap interactions with the human AGO2 MID domain
  23. Translation, stability, and resistance to decapping of mRNAs containing caps substituted in the triphosphate chain with BH3, Se, and NH
  24. Structural requirements for Caenorhabditis elegans DcpS substrates based on fluorescence and HPLC enzyme kinetic studies
  25. Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo
  26. Towards mRNA with superior translational activity: synthesis and properties of ARCA tetraphosphates with single phosphorothioate modifications
  27. Recognition of different nucleotidyl-derivatives as substrates of reactions catalyzed by various HIT-proteins
  28. Synthetic mRNA cap analogs with a modified triphosphate bridge – synthesis, applications and prospects
  29. Dual activity of certain HIT-proteins: A. thaliana Hint4 and C. elegans DcpS act on adenosine 5′-phosphosulfate as hydrolases (forming AMP) and as phosphorylases (forming ADP)
  30. Phosphoroselenoate Dinucleotides for Modification of mRNA 5′ End
  31. Drosophila miR2 Primarily Targets the m7GpppN Cap Structure for Translational Repression
  32. Identification of the HIT-45 protein from Trypanosoma brucei as an FHIT protein/dinucleoside triphosphatase: Substrate specificity studies on the recombinant and endogenous proteins
  33. Phosphorothioate analogs of m7GTP are enzymatically stable inhibitors of cap-dependent translation
  34. Synthetic dinucleotide mRNA cap analogs with tetraphosphate 5′,5′ bridge containing methylenebis(phosphonate) modification
  35. Adenosine 5'-Tetraphosphate Is a Highly Potent Purinergic Endothelium-Derived Vasoconstrictor
  36. Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS
  37. mRNA Decapping Is Promoted by an RNA-Binding Channel in Dcp2
  38. Solid-Supported Synthesis of 5′-mRNA CAP-4 from Trypanosomatids
  39. Assignment of the Absolute Configuration of P-Chiral 5′Mrna Cap Analogues Containing Phosphorothioate Moiety
  40. Synthesis of3H and13C Labeled Mrna Cap Dinucleotides—Useful Tools for Nmr, Biochemical, and Biological Studies
  41. Synthesis ofLeishmaniaCap-4 Intermediates, Cap-2 and Cap-3
  42. Affinity of Dinucleotide Cap Analogues for Human Decapping Scavenger (hDcpS)
  43. Kinetics of C. Elegans DcpS Cap Hydrolysis Studied by Fluorescence Spectroscopy
  44. Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells
  45. A simple and rapid synthesis of nucleotide analogues containing a phosphorothioate moiety at the terminal position of the phosphate chain
  46. Interaction of human decapping scavenger with 5′ mRNA cap analogues: structural requirements for catalytic activity
  47. Weak binding affinity of human 4EHP for mRNA cap analogs
  48. Synthesis of Anti‐Reverse Cap Analogs (ARCAs) and their Applications in mRNA Translation and Stability
  49. Enzymatically stable 5′ mRNA cap analogs: Synthesis and binding studies with human DcpS decapping enzyme
  50. Methylene analogues of adenosine 5'-tetraphosphate. Their chemical synthesis and recognition by human and plant mononucleoside tetraphosphatases and dinucleoside tetraphosphatases
  51. Differential Inhibition of mRNA Degradation Pathways by Novel Cap Analogs
  52. A direct method for the synthesis of nucleoside 5′-methylenebis(phosphonate)s from nucleosides
  53. A NOVEL APPROACH TO SOLID PHASE CHEMICAL SYNTHESIS OF OLIGONUCLEOTIDE mRNA CAP ANALOGS
  54. SYNTHESIS AND PROPERTIES OF mRNA CAP ANALOGS CONTAINING PHOSPHOROTHIOATE MOIETY IN 5′,5′-TRIPHOSPHATE CHAIN
  55. SYNTHESIS AND ENZYMATIC CHARACTERIZATION OF METHYLENE ANALOGS OF ADENOSINE 5′-TETRAPHOSPHATE (P4A)
  56. SYNTHESIS AND BIOCHEMICAL PROPERTIES OF NOVEL mRNA 5′ CAP ANALOGS RESISTANT TO ENZYMATIC HYDROLYSIS
  57. NOVEL DINUCLEOSIDE 5′,5′-TRIPHOSPHATE CAP ANALOGUES. SYNTHESIS AND AFFINITY FOR MURINE TRANSLATION FACTOR eIF4E
  58. Influence of Electric Charge Variation at Residues 209 and 159 on the Interaction of eIF4E with the mRNA 5‘ Terminus †
  59. Influence of the Length of the Phosphate Chain in mRNA 5′ Cap Analogues on Their Interaction with Eukaryotic Initiation Factor 4E
  60. Synthesis of Novel mRNA 5′ Cap-Analogues: Dinucleoside P1, P3-Tri-, P1, P4-Tetra-, and P1, P5-Pentaphosphates
  61. Binding Studies of Eukaryotic Initiation Factor eIF4E with Novel mRNA Dinucleotide Cap Analogues
  62. Influence of the Length of the Phosphate Chain in mRNA 5′ Cap Analogues on Their Interaction with Eukaryotic Initiation Factor 4E
  63. Interaction Between Yeast Eukaryotic Initiation Factor eIF4E and mRNA 5′ Cap Analogues Differs from That for Murine eIF4E
  64. Novel "anti-reverse" cap analogs with superior translational properties
  65. Synthesis of tritium labeled isotopomers ofL-tyrosine
  66. Synthesis of tritium labeled [3R‐3H]‐, and [3S‐3H]‐L‐phenylalanine
  67. Synthesis of tritium labeled [3R-3H]-, and [3S-3H]-L-phenylalanine
  68. Tritium Secondary Kinetic Isotope Effect on Phenylalanine Ammonia-Lyase-Catalyzed Reaction
  69. Enzymatic Synthesis of [1-13C]- and [1-14C]-L-Phenyl-Alanine